| CEO: | Adrian Kinkaid |
| Chairman: | Simon Gordon Douglas |
| Chief Scientific Officer: | Richard John Buick |
| Non-Executive Dir: | Matthew Baker, Colin Walsh |
| Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
| Website: | https://www.fusionantibodies.com/ |
| Sector: | Health Care(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BDQZGK16 |
| Currency | UK Pounds |
| Share Price | 14.00p |
| Change Today | -0.25p |
| % Change | -1.75 % |
| 52 Week High | 19.25p |
| 52 Week Low | 5.80p |
| Volume | 243,555 |
| Shares Issued | 113.66m |
| Market Cap | £15.91m |
| RiskGrade | 464 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:02 | 689 @ 14.24p |
| 11:36 | 32,258 @ 13.75p |
| 11:11 | 2,325 @ 13.70p |
| 11:05 | 38,542 @ 14.27p |
| 11:04 | 28,318 @ 14.13p |
| Chair | Simon Gordon Douglas |
| CEO | Adrian Kinkaid |
You are here: research